Diagnostic Value of Immunohistochemical Staining of GP73, GPC3, DCP, CD34, CD31, and Reticulin Staining in Hepatocellular Carcinoma

被引:34
作者
Yao, Shuzhe [1 ]
Zhang, Jianping [1 ]
Chen, Haiyan [1 ]
Sheng, Yan [1 ]
Zhang, Xiaoying [1 ]
Liu, Zhiyan [1 ]
Zhang, Cuijuan [1 ]
机构
[1] Shandong Univ Sch Med, Inst Pathol & Pathophysiol, Jinan 250012, Peoples R China
关键词
hepatocellular carcinoma; immunohistochemistry; GP73; GPC3; CD34; DES-GAMMA-CARBOXYPROTHROMBIN; GLYPICAN-3; EXPRESSION; ALPHA-FETOPROTEIN; SERUM MARKER; CARBOXY PROTHROMBIN; ENDOTHELIAL-CELL; PROGNOSTIC ROLE; LIVER-DISEASE; LESIONS; PROTEIN;
D O I
10.1369/0022155413492771
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It has been reported that Golgi protein-73 (GP73), glypican-3 (GPC3), and des--carboxy prothrombin (DCP) could serve as serum markers for the early detection of hepatocellular carcinoma (HCC). This study aimed to evaluate a panel of immunostaining markers (including GP73, GPC3, DCP, CD34, and CD31) as well as reticulin staining to distinguish HCC from the mimickers. Our results revealed that CD34 immunostaining and reticulin staining were highly sensitive for the diagnosis of HCC. A special immunoreaction pattern of GP73a diffuse coarse-block pattern in a perinuclear region or a concentrated cluster-like or cord-like pattern in a certain part of the cytoplasmwas observed in HCC cells, in contrast to the cytoplasmic fine-granular pattern in surrounding non-tumor cells and non-malignant nodules. This coarse-block pattern correlated significantly with less differentiated HCC. In comparison, GPC3 displayed a good advantage in diagnosing well-differentiated HCC. In our study, DCP and CD31 showed little diagnostic value for HCC as an immunostaining marker. When GP73, GPC3, and CD34 were combined, the specificity improved to 96.6%. Our findings demonstrate for the first time that the immunohistochemical panel of GP73, GPC3, and CD34 as well as reticulin staining is highly specific for the pathological diagnosis of HCC.
引用
收藏
页码:639 / 648
页数:10
相关论文
共 56 条
[1]   No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: A case-control study [J].
Akkiz, Hikmet ;
Bayram, Suleyman ;
Bekar, Aynur ;
Akgollu, Ersin ;
Uskudar, Oguz ;
Sandikci, Macit .
GENE, 2011, 486 (1-2) :104-109
[2]   Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma [J].
Bachert, Collin ;
Fimmel, Claus ;
Linstedt, Adam D. .
TRAFFIC, 2007, 8 (10) :1415-1423
[3]   Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: A tissue microarray analysis of 4,387 tissue samples [J].
Baumhoer, Daniel ;
Tornillo, Luigi ;
Stadlmann, Sylvia ;
Roncalli, Massimo ;
Diamantis, Eva Karamitopoulou ;
Terracciano, Luigi M. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (06) :899-906
[4]   Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma [J].
Beneduce, L. ;
Pesce, G. ;
Gallotta, A. ;
Zampieri, F. ;
Biasiolo, A. ;
Tono, N. ;
Boscato, N. ;
Gatta, A. ;
Pontisso, P. ;
Fassina, G. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (08) :571-577
[5]   Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans [J].
Block, TM ;
Comunale, MA ;
Lowman, M ;
Steel, LF ;
Romano, PR ;
Fimmel, C ;
Tennant, BC ;
London, WT ;
Evans, AA ;
Blumberg, BS ;
Dwek, RA ;
Mattu, TS ;
Mehta, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :779-784
[6]   Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma [J].
Capurro, M ;
Wanless, IR ;
Sherman, M ;
Deboer, G ;
Shi, W ;
Miyoshi, E ;
Filmus, J .
GASTROENTEROLOGY, 2003, 125 (01) :89-97
[7]   Distinction of hepatocellular carcinoma from benign hepatic mimickers using glypican-3 and CD34 immunohistochemistry [J].
Coston, Wanda M. P. ;
Loera, Sofia ;
Lau, Sean K. ;
Ishizawa, Shin ;
Jiang, Zhong ;
Wu, Chin-Lee ;
Yen, Yun ;
Weiss, Lawrence M. ;
Chu, Peiguo G. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (03) :433-444
[8]  
COUVELARD A, 1993, AM J PATHOL, V143, P738
[9]  
de Boer WB, 2000, CANCER CYTOPATHOL, V90, P273, DOI 10.1002/1097-0142(20001025)90:5<273::AID-CNCR2>3.0.CO
[10]  
2-M